Clinical development of new drug-radiotherapy combinations. by Sharma, R, Plummer, R, Stock, J, Greenhalgh, T, Hawkins, M, NCRI CTRad Academia-Pharma Joint Working Group

FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation The... by Dutton, S, Kenealy, N, Love, S, Wasan, H, Sharma, R, on behalf of the FOXFIRE Protocol Development Group and the NCRI Colorectal Clinical Study Group

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials. by Harrison, C, Moorman, A, Richards, S, Mitchell, C, Eden, O, Hann, I, Hill, F, Kinsey, S, Gibson, B, Lilleyman, J, Vora, A, Goldstone, A, Martineau, M, NCRI

Management of hot flushes in UK breast cancer patients: clinician and patient perspectives by Deborah Fenlon, Adrienne Morgan, Priya Khambaita, Pankaj Mistry, Janet Dunn, Mei-Lin Ah-See, Emma Pennery, Myra S. Hunter, on behalf of the NCRI CSG Breast Cancer Symptom Working Party

Get full text

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia by Khan, N, Hills, R, Virgo, P, Couzens, S, Clark, N, Gilkes, A, Richardson, P, Knapper, S, Grimwade, D, Russell, N, Burnett, A, Freeman, S, UK NCRI-AML Study Group

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia by Burnett, A, Russell, N, Hills, R, Kell, J, Nielsen, O, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S, Freeman, S, Milligan, D, Clark, R, behalf of the UK NCRI AML Study Group

A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial by Dennis, M, Burnett, A, Hills, R, Thomas, I, Ariti, C, Severinsen, MT, Hemmaway, C, Greaves, P, Clark, RE, Copland, M, Russell, N, National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients by Shah, V, Sherborne, AL, Johnson, DC, Ellis, S, Price, A, Chowdhury, F, Kendall, J, Jenner, MW, Drayson, MT, Owen, RG, Gregory, WM, Morgan, GJ, Davies, FE, Cook, G, Cairns, DA, Houlston, RS, Jackson, G, Kaiser, MF, NCRI Haematology Clinical Studies Group

A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP) by Thomas Starkey, Maria C. Ionescu, Michael Tilby, Martin Little, Emma Burke, Matthew W. Fittall, Sam Khan, Justin K. H. Liu, James R. Platt, Rosie Mew, Arvind R. Tripathy, Isabella Watts, Sophie Therese Williams, Nathan Appanna, Youssra Al-Hajji, Matthew Barnard, Liza Benny, Alexander Burnett, Jola Bytyci, Emma L. Cattell, Vinton Cheng, James J. Clark, Leonie Eastlake, Kate Gerrand, Qamar Ghafoor, Simon Grumett, Catherine Harper-Wynne, Rachel Kahn, Alvin J. X. Lee, Oliver Lomas, Anna Lydon, Hayley Mckenzie, NCRI Consumer Forum, Hari Panneerselvam, Jennifer S. Pascoe, Grisma Patel, Vijay Patel, Vanessa A. Potter, Amelia Randle, Anne S. Rigg, Tim M. Robinson, Rebecca Roylance, Tom W. Roques, Stefan Rozmanowski, René L. Roux, Ketan Shah, Remarez Sheehan, Martin Sintler, Sanskriti Swarup, Harriet Taylor, Tania Tillett, Mark Tuthill, Sarah Williams, Yuxin Ying, Andrew Beggs, Tim Iveson, Siow Ming Lee, Gary Middleton, Mark Middleton, Andrew Protheroe, Tom Fowler, Peter Johnson, Lennard Y. W. Lee

Get full text

A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP) by Starkey, T, Ionescu, MC, Tilby, M, Little, M, Burke, E, Fittall, MW, Khan, S, Liu, JKH, Platt, JR, Mew, R, Tripathy, AR, Watts, I, Williams, ST, Appanna, N, Al-Hajji, Y, Barnard, M, Benny, L, Burnett, A, Bytyci, J, Cattell, EL, Cheng, V, Clark, JJ, Eastlake, L, Gerrand, K, Ghafoor, Q, Grumett, S, Harper-Wynne, C, Kahn, R, Lee, AJX, Lomas, O, Lydon, A, Mckenzie, H, Panneerselvam, H, Pascoe, JS, Patel, G, Patel, V, Potter, VA, Randle, A, Rigg, AS, Robinson, TM, Roylance, R, Roques, TW, Rozmanowski, S, Roux, RL, Shah, K, Sheehan, R, Sintler, M, Swarup, S, Taylor, H, Tillett, T, Tuthill, M, Williams, S, Ying, Y, Beggs, A, Iveson, T, Lee, SM, Middleton, G, Middleton, M, Protheroe, A, Fowler, T, Johnson, P, Lee, LYW

Other Authors: “…NCRI Consumer Forum…”

NCRI CTRad workshop: translating novel discoveries to and from the clinic by Hak, CCW, Dean, JA, Hill, MA, Somaiah, N

Other Authors: “…NCRI Clinical and Translational Radiotherapy Research Working Group 1…”